Skip to main content
. 2017 Jul 28;23(28):5146–5157. doi: 10.3748/wjg.v23.i28.5146

Figure 7.

Figure 7

Effects of monocyte-based therapy on chronically liver-damaged mice. A: Hepatic levels of TGF-β1; B: Splenic levels of TGF-β1; C and D: Hepatic levels of IL-17 (C) and IL-23 (D). aP < 0.05; bP < 0.01. TGF-β: Transforming growth factor-beta; IL: Interleukin; BMMCs: Bone marrow mononuclear cells.